Kristin Lynne Meagher
Princeton University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kristin Lynne Meagher.
Bioorganic & Medicinal Chemistry Letters | 2002
Richard Eric Mewshaw; Kristin Lynne Meagher; Ping Zhou; Dahui Zhou; Xiaojie Shi; Rosemary Scerni; Deborah H. Smith; Lee E. Schechter; Terrance H. Andree
The design and synthesis of a novel series of indole derivatives (9) having dual 5-HT transporter reuptake and 5-HT(1A) antagonist activity are described.
Bioorganic & Medicinal Chemistry Letters | 2001
Kristin Lynne Meagher; Richard Eric Mewshaw; Deborah A. Evrard; Ping Zhou; Deborah L. Smith; Rosemary Scerni; Taylor Spangler; Susan Abulhawa; Xiaojie Shi; Lee E. Schechter; Terrance H. Andree
A series of indolylcyclohexylamines possessing potent and selective serotonin reuptake inhibition is reported. The most interesting compounds proved to have subnanomolar 5-HT transporter activity, and exhibited moderate 5-HT(1A) affinity.
Tetrahedron Letters | 2001
Ping Zhou; Yanfang Li; Kristin Lynne Meagher; Richard G Mewshaw; Boyd L. Harrison
Abstract A new efficient method for the preparation of 3-(4-pyridinyl)methylindoles has been developed. The new method involves coupling of indoles with 4-pyridinecarboxaldehyde to give 3-indolyl 4-pyridinyl methanols, which upon treatment with triethylsilane in the presence of trifluoroacetic acid afford 3-(4-pyridinyl)methylindoles in 64–76% overall yield.
Bioorganic & Medicinal Chemistry | 2008
Dahui Zhou; Ping Zhou; Deborah A. Evrard; Kristin Lynne Meagher; Michael Byron Webb; Boyd L. Harrison; Donna M. Huryn; Jeannette Golembieski; Geoffrey Hornby; Lee E. Schechter; Deborah L. Smith; Terrance H. Andree; Richard Eric Mewshaw
Based on the previously reported discovery lead, 3-(cis-4-(4-(1H-indol-4-yl)piperazin-1-yl)cyclohexyl)-5-fluoro-1H-indole (2), a series of related arylpiperazin-4-yl-cyclohexyl indole analogs were synthesized then evaluated as 5-HT transporter inhibitors and 5-HT(1A) receptor antagonists. The investigation of the structure-activity relationships revealed the optimal pharmacophoric elements required for activities in this series. The best example from this study, 5-(piperazin-1-yl)quinoline analog (trans-20), exhibited equal binding affinities at 5-HT transporter (K(i)=4.9nM), 5-HT(1A) receptor (K(i)=6.2nM) and functioned as a 5-HT(1A) receptor antagonist.
Archive | 2000
Richard Eric Mewshaw; Ping Zhou; Dahui Zhou; Kristin Lynne Meagher; Magda Asselin; Deborah Ann Evrard; Adam M. Gilbert
Archive | 2000
Richard Eric Mewshaw; Kristin Lynne Meagher
Archive | 2004
Aranapakam Mudumbai Venkatesan; Santos Osvaldo Dos; Magda Asselin; George Theodor Grosu; Deborah Ann Evrard; Richard Eric Mewshaw; Kristin Lynne Meagher
Archive | 2004
Aranapakam Mudumbai Venkatesan; Osvaldo Dos Santos; Magda Asselin; George Theodore Grosu; Deborah Ann Evrard; Richard Eric Mewshaw; Kristin Lynne Meagher
Archive | 2000
Richard Eric Mewshaw; Kristin Lynne Meagher
Archive | 2004
Aranapakam Mudumbai Venkatesan; Santos Osvaldo Dos; Magda Asselin; George Theodor Grosu; Deborah Ann Evrard; Richard Eric Mewshaw; Kristin Lynne Meagher